Search

Cancers evolve during disease progression and under the selective pressure of therapy. Our ability to continually monitor cancer is critical to guide optimal therapeutic choices. Many cancers shed small amounts of DNA (called... Read more

Almost a century ago, pioneering studies by Otto Warburg revealed a fundamental difference between the metabolism of normal and cancer cells. However, it is only in the last decade that significant inroads have been made to... Read more

Call for applications for the 2026 Peter Mac Distinguished Scholars Fund for a PhD in cancer research at Peter Mac in 2026. This award was previously known as the Peter Mac Foundation Award.   The Peter Mac... Read more

The vision of the Clemons lab is to improve outcomes for gastro-oesophageal cancer patients through better treatment selection and development of new treatment strategies. These goals are built on a foundation of an in depth... Read more

Many breast and ovarian cancer run in families (termed hereditary cancers), but only about a third of these familial cancers are caused by genes we know about such as BRCA1 and BRCA2. Women with a family history of hereditary... Read more

Ovarian cancer is one of the deadliest cancers in women, and a greater understanding of the molecular events is urgently needed to identify new targets for treatment. The Kylie Gorringe Lab addresses this goal by using... Read more